Neurohormonal activation and left ventricular ejection fraction in patients with suspected myocardial ischemia

International Journal of Cardiology

Volumn 120, Issue 2, 2007, Pages 248-253

  Wermuth, Juerg ^a   Staub, Daniel ^a   Laule Kilian, Kirsten ^a   Nusbaumer, Charly ^a   Breidthardt, Tobias ^a   Hochholzer, Willibald ^a   Christ, Michael ^a   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Left ventricular ejection fraction; Natriuretic peptides; Scar

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM ANTAGONIST; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; ERGOMETRY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HORMONAL REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VENTRICULAR FUNCTION, LEFT;

EID: 34447292987     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.10.003     Document Type: Article

References (29)

1. Mukoyama M., Nakao K., Hosoda K., et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87 (1991) 1402-1412
2. Yasue H., Yoshimura M., Sumida H., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
3. Davis M., Espiner E., Richards G., et al. Plasma brain natriuretic peptide in assessment of acute dyspnea. Lancet 343 (1994) 440-444
4. McDonagh T.A., Robb S.D., Murdoch D.R., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
5. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
6. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
7. Bibbins-Domingo K., Ansari M., Schiller N.B., et al. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 108 (2003) 2987-2992
8. Grech E.D. Pathophysiology and investigation of coronary artery disease. BMJ 326 (2003) 1027-1030
9. Sabatine M.S., Morrow D.A., deLemos J.A., et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 44 (2004) 1988-1995
10. Richards A.M., Nicholls M.G., Espiner E.A., et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107 (2003) 2786-2792
11. DeLemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
12. Kragelund C., gronning B., Kober L., Hildebrandt P., and Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352 (2005) 666-675
13. Berman D.S., Hosen K., Friedman J.D., et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 22 (1993) 1455-1464
14. Hachamovitch R., Berman D.S., Kiat H., et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93 (1996) 905-914
15. Hachamovitch R., Berman D.S., Shaw L.J., et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 97 (1998) 535-543
16. Mueller T., Gegenhuber A., Poelz W., et al. Preliminary evaluation of the AxSyM B-type natriuretic peptide (BNP) assay and comparison with the ADVIA Centaur BNP assay. Clin Chem 50 (2004) 1104-1106
17. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
18. Aurigemma G.P., and Gaasch W.H. Diastolic heart failure. N Engl J Med 351 (2004) 1097-1105
19. Ndrepepa G., Braun S., Mehilli J., et al. Plasma levels of N-terminal pro-brain natriuretic peptide in patients with coronary artery disease and relation to clinical presentation, angiographic severity, and left ventricular ejection fraction. Am J Cardiol 95 (2005) 553-557
20. Hammer-Lercher A., Neubauer E., Müller S., Pachinger O., Puschendorf B., and Mair J. Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide, and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. Clin Chim Acta 310 (2001) 193-197
21. Groenning B.A., Nilsson J.C., Sondergaard L., Kjaer A., Larsson H.B.W., and Hildebrandt P.R. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail 3 (2001) 699-708
22. Nousiainen T., Vanninen E., Jantunen E., et al. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction. J Intern Med 251 (2002) 228-234
23. Maisel A.S., McCord J., Nowak R.M., et al. Bedside B-type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction: results from the Breathing Not Properly Multinational Study. J Am Coll Cardiol 41 (2003) 2010-2017
24. Kjaer A., Hildebrandt P., Appel J., and Petersen C.L. Neurohormones as markers of right- and left-sided cardiac dimensions and function in patients with untreated chronic heart failure. Int J Cardiol 99 (2005) 301-306
25. McDonagh T.A., Cunningham A.D., Morrrison C.E., et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 86 (2001) 21-26
26. Williams S.G., Ng L.L., O'Brien R.J., et al. Complementary roles of simple variables, NYHA and N-BNP, in indicating aerobic capacity and severity of heart failure. Int J Cardiol 102 (2005) 279-286
27. Vorlat A., Claeys M.J., Bosmans J.M., Van Hoof V., and Vrints C.J. B-type natriuretic peptide and assessment of jeopardised myocardium in acute myocardial infarction. Int J Cardiol (Apr 25 2006) [Electronic publication ahead of print]
28. Notomi Y., Martin-Miklovic M.G., Oryszak S.J., et al. Enhanced ventricular untwisting during exercise: a mechanistic manifestation of elastic recoil described by Doppler tissue imaging. Circulation 113 (2006) 2524-2533
29. Staub D., Nusbaumer C., Zellweger M.J., et al. Use of B-type natriuretic peptide in the detection of myocardial ischemia. Am Heart J 151 (2006) 1223-1230